Their research further presented that TREM2 mRNA expression was negatively correlated with the methylation rate of specific CpG sites in TREM2 intron 1, and therefore the low methylation of CpG sites of TREM2 may serve as an additional marker for AD pathology [57]. Here, TREM2 is linked to Alzheimer disease.